Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novo Nordisk

France steps up monitoring of diabetes drug used for weight loss

The French drug safety agency on Wednesday announced it was stepping up monitoring of Ozempic, a diabetes drug promoted by influencers on social networks who flaunt its weight-loss properties. As well as health concerns, the authorities say the increased demand could jeopardise access for legitimate diabetic patients.

Radio France Internationale

How use of diabetes drug Ozempic for weight loss has led to a shortage: 'Let the diabetics have their drugs'

Ozempic has been catapulted into the public eye in recent months as celebrities and wellness influencers started taking it for weight loss. But Ozempic is a diabetes drug — and the craze has led to a shortage, leaving those who need it for Type 2 diabetes at a loss.

Tribune News Service

Weight loss drug trend on TikTok worries doctors

Paris (AFP) - The diabetes drug Ozempic has become a social media phenomenon for its weight loss properties, but its soaring popularity has led to global shortages and doctors warn about the potential side effects.

AFP

From analysis to the latest developments in health,
read the most diverse news in one place.

CBS '60 Minutes' Story Turns FDA Headlights On Diabetes and Weight Loss Drug Stock

Growth stock Novo Nordisk is showing strength after FDA approval of breakthrough oral drug for type 2 diabetes. Shares are in a base.

Investors Business Daily

Warning over TikTok diet and powerful 'skinny jab' that can be bought online

Under NICE guidelines, Ozempic can only be prescribed to people with Type 2 diabetes who meet certain criteria, such as having a BMI of 30 or more. But the Sunday Mirror discovered the drug can easily be bought online and in beauty salons by people without diabetes.

Irish Mirror

TikTok diet sparks concerns over powerful 'skinny jab' that can be bought online

The 'skinny jab' is usually used as a diabetes drug for weight loss and can be bought online without an NHS prescription but charities are warning it is a loaded gun

Daily Mirror

Weight loss jabs to be sold via high street chemists in England

Appetite suppressant Wegovy, popular with celebrities, seen as breakthrough treatment but not permanent remedy

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Hollywood ‘skinny jab’ to be sold in UK

The drug is used by Hollywood A-listers to help them slim quickly

The Independent UK

Hollywood ‘skinny jab’ set to be sold in UK

The drug is used by Hollywood A-listers to help them slim quickly

The Independent UK

Diabetes sufferers fear shortages of drug after influencers say it helps lose weight

There are thousands of videos on TikTok that claim that you can miraculously lose weight by taking Ozempic, a medicine meant to be used by people with diabetes. As a result, there has been a massive rise in sales of Ozempic worldwide. Now, both doctors and people with diabetes are…

France 24

New diabetes drugs do not tackle root causes of obesity, experts warn

Doctors say preventing obesity by avoiding unhealthy food is better than trying to reverse its effects

The Guardian - UK

Jim Cramer Gushes Over Pharmaceutical Stock's Chart: 'About The Greatest You've Ever Seen'

CNBC's Jim Cramer has a lot to say about Wegovy, Novo Nordisk's fast-selling weight loss treatment.

The Street

Prime-Time Battles Drive GSK And Novo Nordisk In 2023; Novartis Preps Its Spinoff

GSK stock and NVO stock rose Wednesday, though both beat forecasts. Novartis stock skidded on lighter-than-expected sales.

Investors Business Daily

Wegovy works. But here's what happens if you can't afford to keep taking the drug

The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Sun-Times

With weight-loss prescriptions causing shortage of diabetes drug Ozempic, diabetics struggle to find drug they depend on

TikTok videos about Ozempic as a weight-loss aid have gotten millions of views. The shortages are having a “ripple effect” on supplies of other diabetes medications.

Salon

Drugmakers sued over insulin prices

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market

Investors Business Daily

How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer, Eli Lilly

The Food and Drug Administration expanded the label for Novo Nordisk's oral diabetes medicine, leading NVO stock to jump Friday.

Tribune News Service

Eli Lilly, insulin makers sued by California over prices

Eli Lilly & Co., Novo Nordisk AS and Sanofi were sued by California over insulin prices, which the state claims are inflated through unfair and deceptive practices and disproportionately affect low-income households and people of color.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

California latest to sue drug companies over insulin prices

California says it will sue the companies that make and promote much of the nation's insulin

The Independent UK

New guidance: Use drugs, surgery early for obesity in kids

New guidelines suggest children struggling with obesity should be evaluated and treated early and aggressively

ABC News

Semaglutide is causing a social media frenzy. So what is it?

It is not a a viral meme, but a drug that is an injectable medication — originally designed to treat diabetes — that has left those who need it waiting until next year for resupply.

Axios

The growing market for weight loss drugs

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

Investors Business Daily

Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly

Amgen is years behind rivals in developing an obesity treatment, but the company says its experimental drug could prove superior.

Investors Business Daily

Amgen Is The Underdog In Obesity Treatment — But It's Creeping Up On Novo Nordisk, Eli Lilly

Amgen stock dipped Thursday though the company unveiled promising results for its experimental obesity treatment.

Investors Business Daily

Novo Nordisk Stock Flashing Renewed Technical Strength

Novo Nordisk ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Department of Health and Social Care

143 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.